Veterinary Medicines

Vetoryl 60 mg Chewable Tablets for Dogs

Authorised
  • Trilostane
Download as PDF

Product identification

Medicine name:
Vetoryl 60 mg chewable tablets for dogs
Vetoryl 60 mg Chewable Tablets for Dogs
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    60.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Aluminium – Polyamide/Aluminium/PVC blister.Each blister contains 10 tablets. Cardboard box of 1 blister.
  • Aluminium – Polyamide/Aluminium/PVC blister.Each blister contains 10 tablets. Cardboard box of 3 blisters.
  • Aluminium – Polyamide/Aluminium/PVC blister.Each blister contains 10 tablets. Cardboard box of 5 blisters.
  • Aluminium – Polyamide/Aluminium/PVC blister.Each blister contains 10 tablets. Cardboard box of 6 blisters.
  • Aluminium – Polyamide/Aluminium/PVC blister.Each blister contains 10 tablets. Cardboard box of 10 blisters.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 50406/3004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0514/008
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."